Abstract
Thyrotoxicosis resulting from functional thyroid cancer metastases is extremely rare, and is mostly caused by follicular cancer. The lesions causing thyrotoxicosis are usually bulky and extensive. We report here a patient with Graves’ disease and concomitant papillary thyroid cancer who developed metastases causing symptomatic thyrotoxicosis. His serum titers of thyroid stimulating Ig (TSIs) were elevated. We believe that TSIs were responsible for thyrotoxicosis by stimulating hormonogenesis in the metastatic lesions.
Similar content being viewed by others
References
Belfiore A., Garofalo M.R., Giuffrida D., et al. Increased aggressiveness of thyroid cancer in patients with Graves’ disease. J. Clin. Endocrinol. Metab. 1990, 70: 830–835.
Pellegriti G., Belfiore A., Giuffrida D., Lupo L., Vigneri R. Outcome of differentiated thyroid cancer in Graves’ patients. J. Clin. Endocrinol. Metab. 1998, 83: 2805–2809.
Clark O.H. TSH suppression in the management of thyroid nodules and thyroid cancer. World J. Surg. 1981, 5: 39–47.
Mazzaferri E.L. Thyroid cancer and Graves’ disease. J. Clin. Endocrinol. Metab. 1990, 70: 826–829.
Paul S.J., Sisson J.C. Thyrotoxicosis caused by thyroid cancer. Endocrinol. Metab. Clin. North Am. 1990, 19: 593–612.
Oppenheim A., Miller M., Anderson G.H. Jr, Davis B., Slagle T. Anaplastic thyroid cancer presenting with hyperthyroidism. Am. J. Med. 1983, 75: 702–704.
Edmonds C.J., Thompson B.D. Hyperthyroidism induced by secondary carcinoma in the thyroid. Clin. Endocrinol. (Oxf.) 1978, 8: 411–415.
Shimaoka K., VanHerle A.J., Dindogru A. Thyrotoxicosis secondary to involvement of the thyroid with malignant lymphoma. J. Clin. Endocrinol. Metab. 1976, 43: 64–68.
Filetti S., Belfiore A., Amir S.M., et al. The role of thyroidstimulating antibodies of Graves’ disease in differentiated thyroid cancer. N. Engl. J. Med. 1988, 318: 753–759.
Basaria S., Cooper D.S. Graves’ disease and recurrent ectopic thyroid tissue. Thyroid. 1999, 9: 1261–1264.
Kasagi K., Takeuchi R., Miyamoto S., et al. Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases. Clin. Endocrinol. (Oxf.) 1994, 40: 429–434.
Studer H., Veraguth P., Wyss F. Thyrotoxicosis due to a solitary hepatic metastasis of thyroid carcinoma. J. Clin. Endocrinol. Metab. 1961, 21: 1334.
Valenta L., Lemarchand-Beraud T., Nemec J., Griessen M., Bednar J. Metastatic thyroid carcinoma provoking hyperthyroidism, with elevated circulating thyrostimulators. Am. J. Med. 1970, 48: 72–76.
Snow M.H., Davies T., Smith B.R., et al. Thyroid stimulating antibodies and metastatic thyroid carcinoma. Clin. Endocrinol. (Oxf.) 1979, 10: 413–418.
Girelli M.E., Casara D., Rubello D., Pelizzo M.R., Busnardo B., Ziliotto D. Severe hyperthyroidism due to metastatic papillary thyroid carcinoma with favorable outcome. J. Endocrinol. Invest. 1990, 13: 333–337.
Davies T.F., Roti E., Braveman L.E., Degroot L.J. Thyroid controversy-stimulating antibodies. J. Clin. Endocrinol. Metab. 1998, 83: 3777–3785.
Saravanan P., Dayan C. Thyroid autoantibodies. Endocrinol. Metab. Clin. North Am. 2001, 30: 315–337.
Cerletty J.M., William W.J. Hyperthyroidism due to functioning metastatic thyroid carcinoma. Precipitation of thyroid storm with therapeutic radioactive iodine. J.A.M.A. 1979, 242: 269–270.
Lorberboym M., Mechanick J.I. Accelerated thyrotoxicosis induced by iodinated contrast media in metastatic differentiated thyroid carcinoma. J. Nucl. Med. 1996, 37: 1532–1535.
Nicoloff J.T., Low J.C., Dussault J.H., Fisher D.A. Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man. J. Clin. Invest. 1972, 51: 473–483.
Sisson J.C., Carey J.E. Thyroid carcinoma with high levels of function: treatment with 131I. J. Nucl. Med. 2001, 42: 975–983.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Basaria, S., Salvatori, R. Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves’ disease. J Endocrinol Invest 25, 639–642 (2002). https://doi.org/10.1007/BF03345090
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345090